Ranbaxy Shares Fall after U.S. Drug Recall
March 10, 2014 3:29 PM EST
Shares in Ranbaxy Laboratories Ltd(RANB.NS) fell as much as 3.8 percent on Monday after the drug maker recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after dosage mix-up was detected.
A Ranbaxy office building is pictured in the northern Indian city of Mohali on 14 May, 2013
Shares in Ranbaxy, India's biggest drugmaker by revenue and majority owned by Japan's Daiichi Sankyo Co Ltd (4568.T), were down 2.9 percent at 9:20 a.m., underperforming a 0.3 percent fall in the Nifty.
Join the Conversation
- 5 Proofs Russia is Geared-Up for Shooting War with U.S. and Can Win Future Nuclear Showdown
- ISIS Kidnaps Iraqi Defence Minister’s Family, Executes Female Parliament Candidates
- Bill Clinton At It Again, Caught By Camera In Jerusalem Peeking At Woman’s Breast